713 related articles for article (PubMed ID: 15644622)
1. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.
Miyake-Ogawa C; Miyazaki M; Abe K; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
Am J Nephrol; 2005; 25(1):1-12. PubMed ID: 15644622
[TBL] [Abstract][Full Text] [Related]
2. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
[TBL] [Abstract][Full Text] [Related]
3. Glomerular angiotensin-converting enzyme 2 in pediatric IgA nephropathy.
Urushihara M; Seki Y; Tayama T; Nagai T; Kinoshita Y; Jamba A; Kondo S; Kagami S
Am J Nephrol; 2013; 38(5):355-67. PubMed ID: 24158104
[TBL] [Abstract][Full Text] [Related]
4. Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1.
Lai KN; Chan LY; Tang SC; Tsang AW; Li FF; Lam MF; Lui SL; Leung JC
Kidney Int; 2004 Oct; 66(4):1403-16. PubMed ID: 15458433
[TBL] [Abstract][Full Text] [Related]
5. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
[TBL] [Abstract][Full Text] [Related]
6. Expression of the intrarenal angiotensin receptor and the role of renin-angiotensin system inhibitors in IgA nephropathy.
Zhang Z; Jiang SM; Ma YP; Dai PL; Wang YN; Zou GM; Gao HM; Yang Y; Li WG
Mol Cell Biochem; 2019 Mar; 453(1-2):103-110. PubMed ID: 30159797
[TBL] [Abstract][Full Text] [Related]
7. Presence and physiologic function of the renin-angiotensin system in mouse lacrimal gland.
Yaguchi S; Ogawa Y; Shimmura S; Hatou S; Nakamura S; Inaba T; Imada T; Ozawa Y; Kawakami Y; Ishida S; Tsubota K
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5416-25. PubMed ID: 22786901
[TBL] [Abstract][Full Text] [Related]
8. Visfatin stimulates a cellular renin-angiotensin system in cultured rat mesangial cells.
Huang Q; Guo Y; Zeng H; Xie W; Yan H; Ding H
Endocr Res; 2011; 36(3):93-100. PubMed ID: 21314328
[TBL] [Abstract][Full Text] [Related]
9. Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy.
Masuda S; Tamura K; Wakui H; Maeda A; Dejima T; Hirose T; Toyoda M; Azuma K; Ohsawa M; Kanaoka T; Yanagi M; Yoshida S; Mitsuhashi H; Matsuda M; Ishigami T; Toya Y; Suzuki D; Nagashima Y; Umemura S
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F720-31. PubMed ID: 20685825
[TBL] [Abstract][Full Text] [Related]
10. Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure.
Chan LY; Leung JC; Lai KN
Clin Exp Nephrol; 2004 Dec; 8(4):297-303. PubMed ID: 15619027
[TBL] [Abstract][Full Text] [Related]
11. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy.
Abe K; Miyazaki M; Koji T; Furusu A; Shioshita K; Tsukasaki S; Ozono Y; Harada T; Sakai H; Kohno S
Nephron; 2001 Mar; 87(3):231-9. PubMed ID: 11287758
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of glomerular angiotensin II receptors in IgA nephropathy.
Hale GM; Howarth GS; Aarons I; Clarkson AR; Woodroffe AJ
Clin Nephrol; 1989 Jul; 32(1):5-9. PubMed ID: 2758703
[TBL] [Abstract][Full Text] [Related]
13. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.
Huang XR; Chen WY; Truong LD; Lan HY
J Am Soc Nephrol; 2003 Jul; 14(7):1738-47. PubMed ID: 12819233
[TBL] [Abstract][Full Text] [Related]
14. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
Urata H; Ganten D
Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772
[TBL] [Abstract][Full Text] [Related]
15. Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation.
Wang C; Liu X; Peng H; Tang Y; Tang H; Chen Z; Lou T; Zhang H
Arch Med Res; 2010 May; 41(4):255-60. PubMed ID: 20637368
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin I converting enzyme and chymase in cardiovascular tissues.
Nishimura H; Hoffmann S; Baltatu O; Sugimura K; Ganten D; Urata H
Kidney Int Suppl; 1996 Jun; 55():S18-23. PubMed ID: 8743505
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension.
Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J
J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764
[TBL] [Abstract][Full Text] [Related]
19. Increased ACE and decreased ACE2 expression in kidneys from patients with IgA nephropathy.
Mizuiri S; Hemmi H; Arita M; Aoki T; Ohashi Y; Miyagi M; Sakai K; Shibuya K; Hase H; Aikawa A
Nephron Clin Pract; 2011; 117(1):c57-66. PubMed ID: 20689326
[TBL] [Abstract][Full Text] [Related]
20. Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney.
Abe K; Miyazaki M; Koji T; Furusu A; Ozono Y; Harada T; Sakai H; Nakane PK; Kohno S
Kidney Int; 1998 Jul; 54(1):120-30. PubMed ID: 9648070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
